Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1956 1
1961 6
1962 5
1963 2
1964 4
1965 4
1966 3
1968 3
1969 8
1970 3
1971 3
1972 2
1973 2
1974 11
1975 8
1976 9
1977 10
1978 18
1979 18
1980 24
1981 32
1982 30
1983 40
1984 28
1985 23
1986 20
1987 34
1988 39
1989 38
1990 47
1991 31
1992 52
1993 48
1994 43
1995 52
1996 52
1997 67
1998 69
1999 74
2000 115
2001 100
2002 159
2003 131
2004 150
2005 143
2006 143
2007 145
2008 152
2009 157
2010 171
2011 221
2012 196
2013 176
2014 178
2015 170
2016 182
2017 192
2018 204
2019 197
2020 205
2021 213
2022 240
2023 211
2024 60

Text availability

Article attribute

Article type

Publication date

Search Results

4,649 results

Results by year

Filters applied: . Clear all
Page 1
CD153/CD30 signaling promotes age-dependent tertiary lymphoid tissue expansion and kidney injury.
Sato Y, Oguchi A, Fukushima Y, Masuda K, Toriu N, Taniguchi K, Yoshikawa T, Cui X, Kondo M, Hosoi T, Komidori S, Shimizu Y, Fujita H, Jiang L, Kong Y, Yamanashi T, Seita J, Yamamoto T, Toyokuni S, Hamazaki Y, Hattori M, Yoshikai Y, Boor P, Floege J, Kawamoto H, Murakawa Y, Minato N, Yanagita M. Sato Y, et al. Among authors: yoshikawa t. J Clin Invest. 2022 Jan 18;132(2):e146071. doi: 10.1172/JCI146071. J Clin Invest. 2022. PMID: 34813503 Free PMC article.
CD83 expression characterizes precursor exhausted T cell population.
Wu Z, Yoshikawa T, Inoue S, Ito Y, Kasuya H, Nakashima T, Zhang H, Kotaka S, Hosoda W, Suzuki S, Kagoya Y. Wu Z, et al. Among authors: yoshikawa t. Commun Biol. 2023 Mar 11;6(1):258. doi: 10.1038/s42003-023-04631-6. Commun Biol. 2023. PMID: 36906640 Free PMC article.
Author's reply.
Arao K, Yoshikawa T. Arao K, et al. Among authors: yoshikawa t. J Cardiol. 2023 Jul;82(1):84-85. doi: 10.1016/j.jjcc.2023.04.010. Epub 2023 Apr 20. J Cardiol. 2023. PMID: 37086968 No abstract available.
[Preface].
Yoshikawa T, Okamura N. Yoshikawa T, et al. Nihon Yakurigaku Zasshi. 2021;156(6):323. doi: 10.1254/fpj.21040. Nihon Yakurigaku Zasshi. 2021. PMID: 34719561 Japanese. No abstract available.
Histamine and Microglia.
Iida T, Yanai K, Yoshikawa T. Iida T, et al. Among authors: yoshikawa t. Curr Top Behav Neurosci. 2022;59:241-259. doi: 10.1007/7854_2022_322. Curr Top Behav Neurosci. 2022. PMID: 35538301 Review.
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study.
Shitara K, Rha SY, Wyrwicz LS, Oshima T, Karaseva N, Osipov M, Yasui H, Yabusaki H, Afanasyev S, Park YK, Al-Batran SE, Yoshikawa T, Yanez P, Dib Bartolomeo M, Lonardi S, Tabernero J, Van Cutsem E, Janjigian YY, Oh DY, Xu J, Fang X, Shih CS, Bhagia P, Bang YJ; KEYNOTE-585 investigators. Shitara K, et al. Among authors: yoshikawa t. Lancet Oncol. 2024 Feb;25(2):212-224. doi: 10.1016/S1470-2045(23)00541-7. Epub 2023 Dec 19. Lancet Oncol. 2024. PMID: 38134948 Clinical Trial.
Divide-and-Conquer Linear-Scaling Quantum Chemical Computations.
Nakai H, Kobayashi M, Yoshikawa T, Seino J, Ikabata Y, Nishimura Y. Nakai H, et al. Among authors: yoshikawa t. J Phys Chem A. 2023 Jan 26;127(3):589-618. doi: 10.1021/acs.jpca.2c06965. Epub 2023 Jan 11. J Phys Chem A. 2023. PMID: 36630608 Review.
Pancreatic RECK inactivation promotes cancer formation, epithelial-mesenchymal transition, and metastasis.
Masuda T, Fukuda A, Yamakawa G, Omatsu M, Namikawa M, Sono M, Fukunaga Y, Nagao M, Araki O, Yoshikawa T, Ogawa S, Masuo K, Goto N, Hiramatsu Y, Muta Y, Tsuda M, Maruno T, Nakanishi Y, Masui T, Hatano E, Matsuzaki T, Noda M, Seno H. Masuda T, et al. Among authors: yoshikawa t. J Clin Invest. 2023 Sep 15;133(18):e161847. doi: 10.1172/JCI161847. J Clin Invest. 2023. PMID: 37712427 Free PMC article.
4,649 results